News | Womens Cardiovascular Health | February 09, 2022

SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization

Figure 1Recommended Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. ∗While not marketed in the United States, DCBs are available for clinical use in Canada, with 1-3 months of DAPT recommended. DAPT = dual antiplatelet therapy; LD, limited data. Reprinted from Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915-2931, with permission from

February 9, 2022 — A newly released expert consensus statement on sex-specific considerations in myocardial revascularization aims to summarize available literature on myocardial revascularization in women and identify important gaps in evidence. The document was published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), the official journal of SCAI.

Cardiovascular disease is the leading cause of death and disability in women globally, claiming the lives of nearly 8.5 million women each year. Utilization of cardiovascular procedures is far lower in women than men, and women continue to be underrepresented in cardiovascular clinical trials, severely limiting the opportunity to better understand sex differences in cardiovascular drug or device outcomes. Current practice guidelines do not address gender-based differences and fail to highlight when insufficient evidence exists regarding cardiovascular outcomes in women, resulting in overall poorer outcomes.

“This consensus is an international collaborative effort that highlights the knowns, the gaps and ambiguities in evidence related to sex-specific revascularization,” said Alexandra Lansky, MD, FSCAI, Chair of the document, Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital. Lansky is also Editor-in-Chief of JSCAI.  “As a companion to the recent percutaneous coronary intervention (PCI) guidelines, it will inform clinicians on best practices most relevant to our female patients and draws attention to areas in need of additional evidence,” Lansky continued. 

The paper explores gaps in evidence in several areas including the epidemiology of ischemic heart disease, diagnostic tools to guide coronary revascularization, revascularization for chronic coronary syndromes, revascularization for non-ST-elevation myocardial infarction (MI) and ST-elevation MI, and revascularization consideration for specific patient populations, vascular access in women, and more.

“Physicians can use this consensus document to inform their discussions with female patients on the risks and benefits of coronary revascularization,” said J. Dawn Abbott, MD, FSCAI, Co-Chair of the document and Professor of Medicine and Director of the Interventional Cardiology Fellowship Training Program at Brown Medical School. “An understanding of the limitations of the data is important in this regard,” Abbott concluded. 

Authors of the paper state that while the evidence supporting clinical decisions in women is lacking, these findings are important to guide prospective investigation and establish research priorities. 

For more information: www.scai.org


Related Content

News | Womens Cardiovascular Health

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Home July 08, 2025
Home
News | Womens Cardiovascular Health

April 22, 2025 — Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University ...

Home April 22, 2025
Home
News | Womens Cardiovascular Health

July 22, 2024 — Nieca Goldberg, MD, a board-certified cardiologist, educator, author, and advocate for women’s health ...

Home July 22, 2024
Home
News | Womens Cardiovascular Health

June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist ...

Home June 27, 2024
Home
News | Womens Cardiovascular Health

April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to ...

Home April 29, 2024
Home
News | Womens Cardiovascular Health

April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to ...

Home April 02, 2024
Home
News | Womens Cardiovascular Health

April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume ...

Home April 02, 2024
Home
News | Womens Cardiovascular Health

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, will ...

Home November 28, 2023
Home
News | Womens Cardiovascular Health

May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials ...

Home May 10, 2023
Home
News | Womens Cardiovascular Health

March 29, 2023 — More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men ...

Home March 29, 2023
Home
Subscribe Now